Study finds new potential therapy option for patients with chronic lymphocytic leukemia
Ohio State University Wexner Medical CenterResearchers continue to refine and improve targeted drug therapies that have changed the most common form of adult leukemia – from an incurable to a chronic condition. New data published in the New England Journal of Medicine offers another treatment option for patients who have stopped responding to the first and second generation drugs.